News for Healthier Living

First-of-Its-Kind Genomic Test Predicts Benefit From Hormone Therapy Added to Radiation for Recurrent Prostate Cancer

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery -- the first predictive biomarker in this setting.

September 28, 2025


October 6 2025

October 5 2025

October 4 2025

October 3 2025

October 2 2025

October 1 2025

September 30 2025

September 29 2025

September 28 2025

September 27 2025

September 26 2025

September 25 2025

September 24 2025

September 23 2025

September 22 2025